Thierry Naas

High Frequency Retrotransposition in Cultured Mammalian Cells

John V. Moran, Susan E. Holmes, Thierry Naas et al. · Cell · 1996 · 1K citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

Matteo Bassetti, Roger Echols, Yuko Matsunaga et al. · The Lancet Infectious Diseases · 2020 · 792 citations

Life Sciences, Infectious Diseases, Microbiology +14

Beta-lactamase database (BLDB) – structure and function

Thierry Naas, Saoussen Oueslati, Rémy A. Bonnin et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2017 · 686 citations · Full text

Life Sciences, Bioinformatics, Microbiology +15

Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a <i>Pseudomonas aeruginosa</i> Clinical Isolate in France

Laurent Poirel, Thierry Naas, Delphine Nicolas et al. · Antimicrobial Agents and Chemotherapy · 2000 · 558 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Genetic Structures at the Origin of Acquisition of the β-Lactamase <i>bla</i> _KPC Gene

Thierry Naas, Gaëlle Cuzon, María Virginia Villegas et al. · Antimicrobial Agents and Chemotherapy · 2008 · 534 citations · Full text

Life Sciences, Genetics, Microbiology +17